AFP and hepatocellular carcinoma: In summary, our study highlights the potential of sST2 as a blood-based marker for HCC detection and the enhanced diagnostic performance of combined sST2 and AFP use in HCC screening, suggesting that further research could lead to novel strategies for managing HCC.